Dapagliflozin post-transcatheter aortic valve implantation: the need for further evidence

Eur J Heart Fail. 2022 Mar;24(3):589-590. doi: 10.1002/ejhf.2436. Epub 2022 Jan 31.

Authors

Catarina de Sousa^{1

2}, Fausto J Pinto¹

Affiliations

¹ Cardiovascular Centre of the University of Lisbon (CCUL), Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
² Lusiadas Knowledge Center, Lisbon, Portugal.

PMID: 35060254
DOI: 10.1002/ejhf.2436

No abstract available

Publication types

Editorial
Comment

MeSH terms

Aortic Valve / surgery
Aortic Valve Stenosis* / surgery
Benzhydryl Compounds / therapeutic use
Glucosides / therapeutic use
Heart Failure*
Heart Valve Prosthesis Implantation*
Heart Valve Prosthesis*
Humans
Risk Factors
Transcatheter Aortic Valve Replacement*
Treatment Outcome

Substances

Benzhydryl Compounds
Glucosides
dapagliflozin